Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Core Viewpoint - The company is focusing on enhancing ship operational efficiency and optimizing the age structure of its fleet while exploring the application of new energy vessels in its routes, pending thorough assessments of safety, economic viability, and feasibility [2]. Group 1 - The company is updating its shipping capacity primarily to improve operational efficiency [2]. - The company is optimizing the age structure of its vessels [2]. - The company is researching the application of new energy vessels, which will be implemented only after comprehensive evaluations [2].

（文章来源：证券日报） 证券日报网讯 9月2日晚间，海峡股份发布公告称，公司第八届监事会第十次临时会议审议通过了《关 于取消监事会的议案》《关于购买公司董事及高级管理人员责任保险的议案》。 ...

（文章来源：证券日报） 证券日报网讯 9月2日晚间，海峡股份发布公告称，公司第八届董事会第十三次临时会议审议通过了 《关于修订的议案》等多项议案。 ...

证券日报网讯 9月2日晚间，海峡股份发布公告称，公司将于2025年9月18日召开2025年第六次临时股东 会。本次股东会将审议《关于取消监事会的议案》等多项议案。 （文章来源：证券日报） ...

股票简称：海峡股份 股票代码：002320 公告编号：2025-67 海南海峡航运股份有限公司 关于召开 2025 年第六次临时股东会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中 的虚假记载、误导性陈述或者重大遗漏承担责任。 一、召开会议基本情况 （一）股东会届次：2025 年第六次临时股东会 （二）股东会召集人：公司董事会。2025 年 9 月 2 日，海南海峡航运股份 有限公司（以下简称"公司"或"海峡股份"）召开第八届董事会第十三次临时 会议，以 11 票赞同、0 票反对、0 票弃权，审议通过了《关于召开 2025 年第六 次临时股东会的议案》，董事会决定于 2025 年 9 月 18 日（星期四）召开 2025 年第六次临时股东会。 （三）会议召开的合法、合规性：公司第八届董事会第十二次会议决议召开 2025 年第六次临时股东会。本次股东会的召开符合有关法律、行政法规、部门 规章、规范性文件、深交所业务规则和海峡股份《公司章程》等规定。 （四）会议召开的日期、时间： 现场会议时间：2025 年 9 月 18 日下午 15:00 网络投票时间：通过深圳证券交易所交易系统进行网络 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 股票简称：海峡股份 股票代码：002320 公告编号：2025-64 海南海峡航运股份有限公司 第八届董事会第十三次临时会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚假记载、误导性陈述或者重 大遗漏承担责任。 海南海峡航运股份有限公司（以下简称"公司"或"海峡股份"）于2025年8月29日以OA、电子邮件的形式 向全体董事发出第八届董事会第十三次临时会议通知及相关议案等材料。会议于2025年9月2日以通讯表 决方式举行，本次会议由董事长王然先生主持，会议应出席董事11名，实际出席董事11名，会议的召 集、召开程序符合《公司法》和海峡股份《公司章程》的有关规定。与会董事经充分审议，表决通过了 以下决议： 一、会议以11票同意，0票反对，0票弃权，审议通过了关于修订《公司章程》的议案。 董事会同意对《海南海峡航运股份有限公司股东会议事规则》进行修订，具体包括取消监事会、调整股 东会职权等内容，具体内容详见公司2025年9月3日在巨潮资讯网披露的《海南海峡航运股份有限公司股 东会议事规则》及《海南海峡航运股份有限公司股东会议事规则修 ...

Core Viewpoint - Strait Holdings (002320) announced the appointment of Ms. Wu Linze as the new Vice General Manager of the company [1] Group 1 - The announcement was made on the evening of September 2 [1]

Group 1 - Company announced the resignation of Zhang Ting as Vice General Manager due to personal retirement, but she will continue to serve as Vice Chairman and Director [1] - Wu Linze has been appointed as the new Vice General Manager following the board meeting held on September 2, 2025 [1] - The resignation of Zhang Ting is not expected to impact the company's normal production and operations [1] Group 2 - For the first half of 2025, the revenue composition of the company was as follows: waterway transportation accounted for 92.9%, port operations for 5.4%, and value-added transportation services for 1.7% [1] - The current market capitalization of the company is 18.1 billion yuan [2]

Core Points - The company has revised its board structure, including the number of directors and their qualifications, to enhance governance and accountability [1][2][4] - The board will consist of 11 directors, including 4 independent directors, with one independent director being a professional accountant [1][2] - The term for directors is set at three years, with the possibility of re-election, and they can only be removed by the shareholders' meeting under justified circumstances [1][2][4] Governance Structure - The board of directors is responsible for major company decisions and must report to the shareholders' meeting [1][2] - The board will have the authority to convene shareholder meetings and execute resolutions passed by the shareholders [2][4] - The board is tasked with formulating the company's annual financial budget and investment plans [2][4] Investment and Financial Management - The board will decide on the company's operational plans, investment strategies, and financial allocations [2][4] - Specific thresholds for investment approvals have been established, such as a single investment limit of 100 million yuan for non-financial equity investments within the annual plan [4][5] - The board must seek shareholder approval for significant transactions exceeding its authorized limits [4][5] Independent Directors' Role - Independent directors are granted special powers, including the ability to conduct audits and propose meetings to protect minority shareholders' interests [6][8] - They are also responsible for providing independent opinions on matters that may harm the company or minority shareholders [6][8] Meeting Procedures - Board meetings must be held with a quorum of at least half of the directors present, and meetings can be conducted in various formats, including in-person and virtual [9][10] - The notice for board meetings must be sent at least 10 working days in advance for regular meetings and 2 days for emergency meetings [9][10] Documentation and Accountability - All board meetings must be documented, and minutes should include key decisions and attendance [25][28] - Directors are required to sign the meeting minutes, and they have the right to request that their statements be recorded [25][28]